Performance of the cockcroft-GAULT, MDRD and CKD-EPI formulae in non-valvular atrial fibrillation: Which one should be used for risk stratification?

Journal of Atrial Fibrillation

Volumn 6, Issue 3, 2013, Pages 35-44

  Barra, Sérgio ^a   Providência, Rui ^b,c,d   Faustino, Catarina ^c   Paiva, Luís ^c   Fernandes, Andreia ^c   Marques, António Leitão ^c  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b CLINIQUE PASTEUR   (France)

^c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Atrial fibrillation; Mortality; Renal dysfunction; Risk prediction; Stroke

Indexed keywords

AGED; AREA UNDER THE CURVE; ARTICLE; CHADS2 SCORE; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION FORMULA; COCKCROFT GAULT FORMULA; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL PARAMETERS; MODIFICATION OF DIET IN RENAL DISEASE FORMULA; MORTALITY; NONVALVULAR ATRIAL FIBRILLATION; PERFORMANCE; PREDICTION; PROGNOSIS; RISK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 84892894065     PISSN: None     EISSN: 19416911     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001 Jun 13;285(22):2864-70.
2. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584. Epub 2009 Sep 17.
3. Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A, Yusuf S, Wallentin L. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: A Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation. 2012 Apr 3;125(13):1605-16. doi: 10.1161/CIRCULATIONAHA.111.038729. Epub 2012 Feb 28.
4. Hohnloser SH, Hijazi Z, Thomas L, Alexander JH, Amerena J, Hanna M, Keltai M, Lanas F, Lopes RD, Lopez-Sendon J, Granger CB, Wallentin L. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. 2012 Nov; 33(22):2821-30. doi: 10.1093/eurheartj/ehs274. Epub 2012 Aug.
5. Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, Rahman M, Ojo A, Teal VL, Jensvold NG, Robinson NL, Dries DL, Bazzano L, Mohler ER, Wright JT, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Group. Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC). Am Heart J 2010;159:1102-1107.
6. Olesen JB, Lip GY, Kamper AL, Hommel K, Køber L, Lane DA, Lindhardsen J, Gislason GH, Torp-Pedersen C. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med. 2012 Aug 16;367(7):625-35. doi: 10.1056/NEJMoa1105594.
7. Go AS, Fang MC, Udaltsova N, Chang Y, Pomernacki NK, Borowsky L, Singer DE; ATRIA Study Investigators. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2009;119;1363-1369.
8. Arbel Y, Halkin A, Finkelstein A, Revivo M, Berliner S, Herz I, Keren G, Banai S. Impact of Estimated Glomerular Filtration Rate on Vascular Disease Extent and Adverse Cardiovascular Events in Patients Without Chronic Kidney Disease. Can J Cardiol. 2013 Jan 11. pii: S0828-282X(12)01386-4. doi: 10.1016/j.cjca.2012.10.014. [Epub ahead of print].
9. Kastarinen H, Ukkola O, Kesäniemi YA. Glomerular filtration rate is related to carotid intima-media thickness in middle-aged adults. Nephrol Dial Transplant. 2009 Sep;24(9):2767-72. doi: 10.1093/ndt/gfp172. Epub 2009 Apr 15.
10. - [10]- Providência R, Fernandes A, Paiva L, Faustino A, Barra S, Botelho A, Trigo J, Nascimento J, Leitão-Marques A. Decreased glomerular filtration rate and markers of left atrial stasis in patients with nonvalvular atrial fibrillation. Cardiology. 2013;124(1):3-10. doi: 10.1159/000345434. Epub 2012 Dec 13.
11. Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y, Go AS, Patel MR, Mahaffey KW, Halperin JL, Breithardt G, Hankey GJ, Hacke W, Becker RC, Nessel CC, Fox KA, Califf RM; ROCKET AF Steering Committee and Investigators. Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R2CHADS2 Index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) Study Cohorts. Circulation. 2013 Jan 15;127(2):224-32. doi: 10.1161/CIRCULATIONAHA.112.107128. Epub 2012 Dec 3.
12. Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2010 Apr;55(4):648-59. doi: 10.1053/j.ajkd.2009. 12.016. Epub 2010 Feb 26.
13. Matsushita K, Tonelli M, Lloyd A, Levey AS, Coresh J, Hemmelgarn BR; Alberta Kidney Disease Network. Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR. Am J Kidney Dis. 2012 Aug;60(2):241-9. doi: 10.1053/j.ajkd.2012.03.016. Epub 2012 May 4.
14. Stevens LA, Li S, Kurella Tamura M, Chen SC, Vassalotti JA, Norris KC, Whaley-Connell AT, Bakris GL, McCullough PA. Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2011 Mar;57(3 Suppl 2):S9-16. doi: 10.1053/j.ajkd.2010.11.007.
15. Kontos MC, Jamal SM, Ornato JP, Tatum JL, Jesse RL, Anderson FP. Comparison of the modification of diet in renal disease and the Cockcroft-Gault equations for predicting mortality in patients admitted for exclusion of myocardial ischemia. Am J Cardiol. 2008 Jul 15;102(2):140-5. doi: 10.1016/j.amjcard.2008.03.023. Epub 2008 May 28.
16. Choi JS, Kim CS, Bae EH, Ma SK, Ahn YK, Jeong MH, Kim YJ, Cho MC, Kim CJ, Kim SW; Korea Acute Myocardial Infarction Registry Investigators. Predicting outcomes after myocardial infarction by using the Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease study equation: results from the Korea Acute Myocardial Infarction Registry. Nephrol Dial Transplant. 2012 Oct;27(10):3868-74. doi: 10.1093/ndt/gfs344. Epub 2012 Aug 9.
17. Szummer K, Lundman P, Jacobson SH, Lindbäck J, Stenestrand U, Wallentin L, Jernberg T; SWEDEHEART. Cockcroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART). Am Heart J. 2010 Jun;159(6):979-86. doi: 10.1016/j.ahj.2010.03.028.
18. Abu-Assi E, Lear P, Cabanas-Grandío P, Rodríguez-Girondo M, Raposeiras-Roubin S, Pereira-López E, Romaní SG, Gil CP, García-Acuña JM, González-Juanatey JR. A comparison of the CKD-EPI, MDRD-4, and Cockcroft-Gault equations to assess renal function in predicting all-cause mortality in acute coronary syndrome patients. Int J Cardiol. 2012 Dec 4. pii: S0167-5273(12)01475-1. doi: 10.1016/j.ijcard.2012.11. 014. [Epub ahead of print].
19. Slawomir Michalak, Radoslaw Kazmierski, Agnieszka Hellmann, Wieslaw Nowinski and Wojciech Kozubski. CKD-EPI Formula Is Superior to MDRD in Assessment of Glomerular Filtration Rate as the Outcome Predictor in Ischemic Stroke Patients. Neurology. February 12, 2013; 80(Meeting Abstracts 1): P06.266.
20. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Vardas P, Al-Attar N, Alfieri O, Angelini A, Blömstrom-Lundqvist C, Colonna P, De Sutter J, Ernst S, Goette A, Gorenek B, Hatala R, Heidbüchel H, Heldal M, Kristensen SD, Kolh P, Le Heuzey JY, Mavrakis H, Mont L, Filardi PP, Ponikowski P, Prendergast B, Rutten FH, Schotten U, Van Gelder IC, Verheugt FW. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012 Nov;33(21):2719-47. doi: 10.1093/eurheartj/ehs253. Epub 2012 Aug 24.
21. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. evaluation, classification and stratification. Am J Kidney Dis. 2002;39:1-246.
22. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S. Third universal definition of myocardial infarction. Circulation. 2012 Oct 16;126(16):2020-35. doi: 10.1161/CIR.0b013e31826e1058. Epub 2012 Aug 24.
23. Pencina M, D'Agostino R, Steyerberg E. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat. Med 2011; 30(1):11-21.
24. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med 2008; 27:157-172.
25. Guo Y, Wang H, Zhao X, Zhang Y, Zhang D, Ma J, Wang Y, Lip GY. Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation. Int J Cardiol. 2013 Jan 29. pii: S0167-5273(13)00010-7. doi: 10.1016/j.ijcard.2012.12.099. [Epub ahead of print].
26. Roldán V, Marín F, Fernández H, Manzano- Fernández S, Gallego P, Valdés M, Vicente V, Lip GY. Renal Impairment in a "Real-Life" Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding). Am J Cardiol. 2013 Jan 18. pii: S0002-9149(12)02648-3. doi: 10.1016/j.amjcard.2012. 12.045. [Epub ahead of print].
27. Akerblom Å, Wallentin L, Siegbahn A, Becker RC, Budaj A, Buck K, Giannitsis E, Horrow J, Husted S, Katus HA, Steg PG, Storey RF, Åsenblad N, James SK. Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study. Clin Chem. 2012 Jan;58(1):190-9. doi: 10.1373/clinchem.2011.171520. Epub 2011 Nov 29.
28. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS; Chronic Kidney Disease Prognosis Consortium. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012 May 9;307(18):1941-51. doi: 10.1001/jama.2012.3954.
29. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150:604-612. [PubMed: 19414839].
30. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-96.
31. Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, He J, Gupta PC, Ramadas K, Tsugane S, Irie F, Tamakoshi A, Gao YT, Wang R, Shu XO, Tsuji I, Kuriyama S, Tanaka H, Satoh H, Chen CJ, Yuan JM, Yoo KY, Ahsan H, Pan WH, Gu D, Pednekar MS, Sauvaget C, Sasazuki S, Sairenchi T, Yang G, Xiang YB, Nagai M, Suzuki T, Nishino Y, You SL, Koh WP, Park SK, Chen Y, Shen CY, Thornquist M, Feng Z, Kang D, Boffetta P, Potter JD.. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011;364:719-29.
32. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ.Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363:2211-9.
33. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med. 1999;341:427-34.
34. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF.Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006; 355:763-78.
35. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293:1861-7.
36. Herselman M, Esau N, Kruger J-M, Labadarios D, Moosa MR. Relationship Between Body Mass Index and Mortality in Adults on Maintenance Hemodialysis: A Systematic Review. J Ren Nutr. 2010;20:281-92.
37. Banerjee A, Fauchier L, Vourc'h P, Andres CR, Taillandier S, Halimi JM, Lip GY. Renal impairment and ischaemic stroke risk assessment in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation Project. J Am Coll Cardiol. 2013 Mar 21. pii: S0735-1097(13)01113-3. doi: 10.1016/j.jacc.2013.02. 035. [Epub ahead of print].
38. Kilbride HS, Stevens PE, Eaglestone G, Knight S, Carter JL, Delaney MP et al. Accuracy of the MDRD (Modification of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly. Am.J.Kidney Dis. 2013;61:57-66.
39. Schaeffner ES, Ebert N, Delanaye P, Frei U, Gaedeke J, Jakob O, Kuhlmann MK, Schuchardt M, Tölle M, Ziebig R, van der Giet M, Martus P.Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012;157:471-481.
40. Van Pottelbergh G, Van Heden L, Matheï C, Degryse J. Methods to evaluate renal function in elderly patients: A systematic literature review. Age Ageing. 2010 Sep;39(5):542-8. doi: 10.1093/ageing/afq091.
41. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012 Jul 5;367(1):20-9. doi: 10.1056/NEJMoa1114248.